Tags

Type your tag names separated by a space and hit enter

Update on Extensively Drug-Resistant Salmonella Serotype Typhi Infections Among Travelers to or from Pakistan and Report of Ceftriaxone-Resistant Salmonella Serotype Typhi Infections Among Travelers to Iraq - United States, 2018-2019.
MMWR Morb Mortal Wkly Rep. 2020 May 22; 69(20):618-622.MM

Abstract

Ceftriaxone-resistant Salmonella enterica serotype Typhi (Typhi), the bacterium that causes typhoid fever, is a growing public health threat. Extensively drug-resistant (XDR) Typhi is resistant to ceftriaxone and other antibiotics used for treatment, including ampicillin, chloramphenicol, ciprofloxacin, and trimethoprim-sulfamethoxazole (1). In March 2018, CDC began enhanced surveillance for ceftriaxone-resistant Typhi in response to an ongoing outbreak of XDR typhoid fever in Pakistan. CDC had previously reported the first five cases of XDR Typhi in the United States among patients who had spent time in Pakistan (2). These illnesses represented the first cases of ceftriaxone-resistant Typhi documented in the United States (3). This report provides an update on U.S. cases of XDR typhoid fever linked to Pakistan and describes a new, unrelated cluster of ceftriaxone-resistant Typhi infections linked to Iraq. Travelers to areas with endemic Typhi should receive typhoid vaccination before traveling and adhere to safe food and water precautions (4). Treatment of patients with typhoid fever should be guided by antimicrobial susceptibility testing whenever possible (5), and clinicians should consider travel history when selecting empiric therapy.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32437343

Citation

François Watkins, Louise K., et al. "Update On Extensively Drug-Resistant Salmonella Serotype Typhi Infections Among Travelers to or From Pakistan and Report of Ceftriaxone-Resistant Salmonella Serotype Typhi Infections Among Travelers to Iraq - United States, 2018-2019." MMWR. Morbidity and Mortality Weekly Report, vol. 69, no. 20, 2020, pp. 618-622.
François Watkins LK, Winstead A, Appiah GD, et al. Update on Extensively Drug-Resistant Salmonella Serotype Typhi Infections Among Travelers to or from Pakistan and Report of Ceftriaxone-Resistant Salmonella Serotype Typhi Infections Among Travelers to Iraq - United States, 2018-2019. MMWR Morb Mortal Wkly Rep. 2020;69(20):618-622.
François Watkins, L. K., Winstead, A., Appiah, G. D., Friedman, C. R., Medalla, F., Hughes, M. J., Birhane, M. G., Schneider, Z. D., Marcenac, P., Hanna, S. S., Godbole, G., Walblay, K. A., Wiggington, A. E., Leeper, M., Meservey, E. H., Tagg, K. A., Chen, J. C., Abubakar, A., Lami, F., ... Mintz, E. (2020). Update on Extensively Drug-Resistant Salmonella Serotype Typhi Infections Among Travelers to or from Pakistan and Report of Ceftriaxone-Resistant Salmonella Serotype Typhi Infections Among Travelers to Iraq - United States, 2018-2019. MMWR. Morbidity and Mortality Weekly Report, 69(20), 618-622. https://doi.org/10.15585/mmwr.mm6920a2
François Watkins LK, et al. Update On Extensively Drug-Resistant Salmonella Serotype Typhi Infections Among Travelers to or From Pakistan and Report of Ceftriaxone-Resistant Salmonella Serotype Typhi Infections Among Travelers to Iraq - United States, 2018-2019. MMWR Morb Mortal Wkly Rep. 2020 May 22;69(20):618-622. PubMed PMID: 32437343.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Update on Extensively Drug-Resistant Salmonella Serotype Typhi Infections Among Travelers to or from Pakistan and Report of Ceftriaxone-Resistant Salmonella Serotype Typhi Infections Among Travelers to Iraq - United States, 2018-2019. AU - François Watkins,Louise K, AU - Winstead,Alison, AU - Appiah,Grace D, AU - Friedman,Cindy R, AU - Medalla,Felicita, AU - Hughes,Michael J, AU - Birhane,Meseret G, AU - Schneider,Zachary D, AU - Marcenac,Perrine, AU - Hanna,Samir S, AU - Godbole,Gauri, AU - Walblay,Kelly A, AU - Wiggington,Ashley E, AU - Leeper,Molly, AU - Meservey,Elizabeth H, AU - Tagg,Kaitlin A, AU - Chen,Jessica C, AU - Abubakar,Abdinasir, AU - Lami,Faris, AU - Asaad,Asaad M, AU - Sabaratnam,Vickneswaran, AU - Ikram,Aamer, AU - Angelo,Kristina M, AU - Walker,Allison, AU - Mintz,Eric, Y1 - 2020/05/22/ PY - 2020/5/22/entrez PY - 2020/5/22/pubmed PY - 2020/5/23/medline SP - 618 EP - 622 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb. Mortal. Wkly. Rep. VL - 69 IS - 20 N2 - Ceftriaxone-resistant Salmonella enterica serotype Typhi (Typhi), the bacterium that causes typhoid fever, is a growing public health threat. Extensively drug-resistant (XDR) Typhi is resistant to ceftriaxone and other antibiotics used for treatment, including ampicillin, chloramphenicol, ciprofloxacin, and trimethoprim-sulfamethoxazole (1). In March 2018, CDC began enhanced surveillance for ceftriaxone-resistant Typhi in response to an ongoing outbreak of XDR typhoid fever in Pakistan. CDC had previously reported the first five cases of XDR Typhi in the United States among patients who had spent time in Pakistan (2). These illnesses represented the first cases of ceftriaxone-resistant Typhi documented in the United States (3). This report provides an update on U.S. cases of XDR typhoid fever linked to Pakistan and describes a new, unrelated cluster of ceftriaxone-resistant Typhi infections linked to Iraq. Travelers to areas with endemic Typhi should receive typhoid vaccination before traveling and adhere to safe food and water precautions (4). Treatment of patients with typhoid fever should be guided by antimicrobial susceptibility testing whenever possible (5), and clinicians should consider travel history when selecting empiric therapy. SN - 1545-861X UR - https://www.unboundmedicine.com/medline/citation/32437343/Update_on_Extensively_Drug_Resistant_Salmonella_Serotype_Typhi_Infections_Among_Travelers_to_or_from_Pakistan_and_Report_of_Ceftriaxone_Resistant_Salmonella_Serotype_Typhi_Infections_Among_Travelers_to_Iraq___United_States_2018_2019_ L2 - https://doi.org/10.15585/mmwr.mm6920a2 DB - PRIME DP - Unbound Medicine ER -